Despite its apparent importance in hydrogen peroxide removal, humans with genetic deficiency of catalase — "acatalasemia" — or mice genetically engineered to lack catalase completely, suffer few ill effects.
By gene targeting, it has been shown that genetic deficiency of Drosha results in the loss of mature miRNAs.
A genetic deficiency due to mutations in the gene encoding for PNP causes gradual decrease in T-cell immunity.
We therefore expect that this compound may find applications in new therapeutic trials against genetic deficiency disorders.
People with inherent genetic deficiency of soluble zinc-binding protein suffer from acrodermatitis enteropathica, a genetic disease indicated by python like rough and scaly skin.
On one hand, genetic deficiency in production of interferon or certain ISGs (e.g., MX and IFITM proteins) increases the vulnerability to IAV infection (Ciancanelli et al., 2015, 2016).
Transgenic plants expressing the wild-type Apl1 gene restored starch levels to near normal levels, indicating that the introduced gene products complemented the genetic deficiency in TL46 plants.
This suggests that, at least in the mouse, genetic deficiency of any 1 isoform of nitric oxide synthase does not result in pregnancy-induced hypertension.
In human, PNP is the only route for degradation of deoxyguanosine and genetic deficiency of this enzyme leads to profound T-cell mediated immunosuppression.
The genetic deficiency of hypoxanthine guanine phosphoribosyltranferase (HPRT), located on the X chromosome, causes a severe neurological disorder in man, known as Lesch Nyhan disease (LND).
In human, purine nucleoside phosphorylase (HsPNP) is responsible for degradation of deoxyguanosine and genetic deficiency of this enzyme leads to profound T-cell mediated immunosuppression.
